The Column Group is a venture capital firm dedicated to developing biotechnology companies.
The Column Group is a leading venture capital firm dedicated to creating the next generation of biotechnology companies
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 29, 2022
Cajal Neuroscience
|
Series A | $96M | Biotechnology | Yes |
Jan 6, 2022
Eikon Therapeutics
|
Series B | $518M | Biotechnology | — |
May 5, 2021
Eikon Therapeutics
|
Series A | $148M | Biotechnology | Yes |
Mar 1, 2021
Tenaya Therapeutics
|
Series C | $106M | Biopharma | — |
Oct 6, 2020
A2 Biotherapeutics
|
Series B | $71.50M | Biotechnology | — |